Alpha-GPC 250 mg (60 capsules)

Alpha-GPC (Alpha-glycerylphosphorylcholine) also called GPC (glycerophosphocholine) 250 mg

A naturally occurring phospholipid precursor and metabolite derived from soy lecithin.

Get complete Alpha-GPC information below:

Promote Mental Focus, Strength & More!

BioSynergy Alpha GPC is the best form of Alha GPC you can buy.

Made from the highest quality raw materials with guaranteed potency:

Other ingredients: Cellulose, Stearic Acid (vegetable source), and Silicon Dioxide.

About other ingredients

Contains no: yeast, wheat, gluten, corn, milk, egg, sugar or salt.

Suggested Usage: As a dietary supplement, take one capsule 1 to 2 times daily with or between meals. Consider taking this product in combination with BioSynergy Neuro Clear and Bio-G.

Alpha-GPC Possible Benefits:

Medline summary:

Alpha-GPC or GPC has been documented extensively by published studies in both animals and humans to contribute to at least five (5) significant human health functions.

These relevant 'mind-body' activities include, but may not be limited to the following:

1. Increases human Growth Hormone (hGH)

Increases in endogenous human Growth Hormone (hGH) secretion by the anterior pituitary in conjunction with Growth Hormone Releasing Hormone (GHRH); that is, both Alpha-GPC and GHRH act concertedly to stimulate the release of hGH, naturally;

2. Improved mental focus and stimulation of cognitive function

Stimulation of the enzymatic synthesis of phosphatidylcholine (PC) in nerves, muscle cells and all cell membranes, counteracting the age-related decrease in phospholipid (PC) biosynthesis; thus, Alpha-GPC contributes directly to improved mental focus and stimulation of cognitive function;

3. More strength from work-outs and training programs

Acts as a precursor of acetylcholine (ACh); thus, Alpha-GPC activates cholinergic transmission which permits the development of more strength from work-outs and training programs, plus reducing levels of somatostatin in the hypothalamic-pituitary axis;

4. Improved lipotrophic functions in the liver

Elevations in blood and tissue levels of the essential nutrient, choline, which supports improved lipotrophic functions (methyl group transferases) in the liver. Research has shown that fatty liver, a condition associated with obesity, diabetes and heavy alcohol consumption, often leads to cirrhosis of the liver or liver failure. Studies conducted by Alan L. Buchman, M.D., associate professor of medicine at The Feinberg School of Medicine at Northwestern University, have shown that fatty liver can be prevented and possibly even eliminated with increased levels of choline. Alpha-GPC also acts synergistically with the body's store (and/or supplementation) of S-adenosyl-L-methionine (SAM or SAMe) and folic acid, vitamin B12 and vitamin B6 to facilitate methyl group transfers in the brain and liver;

5. Improved balanced and coordination

Produces improved balanced and coordination when combined with 'skill set' practice and training as a result of normalized nerve transmission in the brain, and in cardiac, skeletal and smooth muscles.

More Alpha-GPC Information & Possible Benefits:

Alpha-GPC has been shown to potentiate the effects of growth hormone releasing hormone (GHRH) and increase human growth hormone (hGH) secretion in young and elderly individuals. Alpha-GPC also affects numerous biochemical and neurotransmitter systems that have been implicated in the development of age-related memory dysfunction (ARMD).

Alpha-GPC improve memory, attention, and performance in healthy individuals. Alpha-GPC's cognitive and growth hormone (GH) enhancing effects appear to be primarily the result of stimulation of the cholinergic neurotransmitter system; however, other biochemically-related modulations and neurotransmitter systems have been implicated.

Aging and prolonged stress - including athletic endeavors like marathons or 'ironman/ironwoman' events are associated with decreased hormone production, especially reduced secretion of human Growth Hormone (hGH) from the anterior pituitary. These life events are also associated with lower levels of free choline in the blood and tissues. Concomitantly, both quality of life and lifespan decrease, sexual desire and potency diminish, muscles loose both protein (mass) and tone, and body fat levels increase.

In clinical situations, significantly reduced secretion of hGH is associated with short stature, generalized muscle wasting, Andropause, anxiety, undesirable mood and affect changes which are often associated with depression, abnormal sleep patterns, loss of energy and stamina, and decreased cellular and humoral (antibody) immune functions leading to increased susceptibility to disease. Since 1984, the Food and Drug Administration (FDA) has approved the use of recombinant human Growth Hormone (hGH) for the treatment of dwarfism due to hGH deficiency, Adult Onset Growth Hormone Deficiency (Somatopause), Turner's syndrome, and wasting associated with AIDS/HIV. Alpha-GPC can be used in anti-aging programs, as a less expensive alternative to injecting recombinant hGH, and to treat or reduce the symptoms of the Somatopause.

Fate and distribution studies demonstrate that orally administered Alpha-GPC is absorbed quickly from the gastrointestinal tract and is transported in the blood to all cells and tissues, especially the brain. Alpha-GPC crosses the 'blood-brain' barrier and acts as a central nervous system (CNS) cholinergic stimulant while it simultaneously increases the GHRH-stimulated secretion of hGH by the somatotrophe cells in the anterior pituitary. The current understanding of Alpha-GPC's actions in the brain is that it increases hGH secretion in the pituitary by two (2) separate but interacting neuro-endocrine mechanisms; these are:

1. Modulatory - increasing cholinergic tone lending to decreased levels of somatostatin (produced by the hypothalamus), as a result of the administration of Alpha-GPC;

2. Regulatory - stimulation of hGH synthesis resulting from 'up regulation' of Growth Hormone Releasing Hormone/Factor (GHRH/GHRF) in conjunction with receptor-linked stimulation of the adenylate cyclase (cAMP)-Protein kinase C (PKC)-inositol triphosphate (IP3) intracellular control mechanisms regulating hGH synthesis at the genomic level and its subsequent secretion by the anterior pituitary.

Alpha-GPC has been administered to over three thousand (3,000) patients and volunteers in clinical trials and studies that have been published in the peer-reviewed literature. Minor, transient side effects have been reported to occur at a one percent (1%) frequency; these side effects, for orally administered Alpha-GPC, included diarrhea, dizziness, gastralgis, heartburn, insomnia, restlessness and skin rashes, which resolved when the amount of Alpha-GPC administered was either decreased or eliminated.

Alpha-GPC in the mental recovery of transient ischemic attacks or accute stroke.
Institute of Internal Medicine and Geriatrics, University of Palermo, Italy.

The clinical efficacy and the tolerability of alpha-glycerophosphocholine (alpha-GPC), a drug able to provide high levels of choline for the nervous cells of the brain and to protect their cell walls, have been tested in a clinical open multicenter trial on 2044 patients suffering from recent stroke or transient ischemic attacks. alpha-GPC was administered after the attack at the daily dose of 1000 mg im for 28 days and orally at the dose of 400 mg tid during the following 5 months after the first phase. The evaluation of the efficacy on the psychic recovery was done by the Mathew Scale (MS) during the period of im drug administration, and using the Mini Mental State Test (MMST), the Crichton Rating Scale (CRS), and the Global Deterioration Scale (GDS) during the following period of oral administration. The MS mean increased 15.9 points in 28 days in a statistically significant way (p < 0.001) from 58.7 to 74.6. At the end of the 5 month oral administration, the CRS mean significantly decreased 4.3 points, from 20.2 to 15.9 (p < 0.001); the MMST mean significantly increased (p < 0.001) from 21 to 24.3 at the end of the trial, reaching the "normality" score at the 3rd month assessment. The GDS score at the end of the trial corresponded to "no cognitive decline" or "forgetfulness" in 71% of the patients. Adverse events were complained of by 44 patients (2.14%); in 14 (0.7%) the investigator preferred to discontinue therapy. The most frequent complaints were heartburn (0.7%), nausea-vomit (0.5%), insomnia-excitation (0.4%), and headache (0.2%). The trial confirms the therapeutic role of alpha-GPC on the cognitive recovery of patients with acute stroke or TIA, and the low percentage of adverse events confirms its excellent tolerability.(ann ny acad sci 1994 June)

Alpha-GPC Possible Side Effects:

At this time there are no clinically proven side effects with Alpha-GPC when used appropriately. If you are taking any prescribed drugs from your physician, please check the Drug Interactions before taking this nutritional supplement.

Alpha-GPC Dosage:

As a dietary supplement, take one capsule 1 to 2 times daily with or between meals. Consider taking this product in combination with BioSynergy Neuro Clear and Bio-G.

Alpha-GPC Reviews:

See the "Reviews" tab above.

Scroll up to add Alpha-GPC to your cart!

*The above statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.